Social media

Discover how GMP manufacturing can improve trial outcomes, reduce risk, and support regulatory success. During this webinar we will discuss the differences between GMP and USP compounding, and feature expert-led case stu...

Customer advocacy is not a trend, it’s a transformation. It represents a shift from service to stewardship and from expertise to empathy. It’s about recognising that behind every clinical milestone, every regulatory subm...

In the dynamic world of life sciences, the consultancy sector is undergoing a transformation as cost pressures increase, speed to market needs accelerate and technology permeates every aspect. Against this backdrop, cl...

Attending AASLD 2025? Speak with our experts at booth #1041 to learn about our experience-driven country feasibility and site selection, hepatology-specific strategies for recruitment and retention, and advanced imaging ...

Attending AASLD 2025? Speak with our experts at booth \#1041 to learn about our experience-driven country feasibility and site selection, hepatology-specific strategies for recruitment and retention, and advanced imaging...

PubsHub Journals & Congresses scans for predatory practices, and suspicious journals and congresses. Trust it to protect your research work and help you make better informed publishing decisions. Get more info and a demo...

PubsHub Journals & Congresses scans for predatory practices, and suspicious journals and congresses. Trust it to protect your research work and help you make better informed publishing decisions. Get more info and a demo...

Attending #ObesityWeek on Nov 4–7? Meet us as booth \#520 to learn how our comprehensive lab and imaging capabilities support high-quality, large-scale obesity studies. From AI-driven imaging biomarkers to expert guidanc...

We’re heading to #ISPOREurope in Glasgow (Nov 9–12)! Visit ICON at Booth 824 to explore how we advance HEOR, RWE, and market access strategies for better patient outcomes. https://ow.ly/eumN50XfmbW #ISPOREurope #HEOR #...

We’re heading to #ISPOREurope in Glasgow (Nov 9–12)! Visit ICON at Booth 824 to explore how we advance HEOR, RWE, and market access strategies for better patient outcomes. https://ow.ly/xEsm50XfmbV #ISPOREurope #HEOR #...

ICON reports third quarter 2025 results. Quarter three revenue was $2,042.8 million representing an increase of 1.3% on quarter two 2025. Net business wins in the quarter of $2,086 million, representing an increase of 1....

USP compounding may be fast — but is it costing you quality, compliance, and insight? Join our webinar to learn why GMP is the smarter choice for early phase trials. During this session we will discuss: • The differences...